About MiMedx Group, Inc.
https://www.mimedx.comMiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins.
CEO
Joseph H. Capper
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2008-04-02 | Reverse | 647:2000 |
ETFs Holding This Stock
Summary
Showing Top 3 of 127
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
ESSEX WOODLANDS MANAGEMENT, INC.
Shares:28.2M
Value:$160.43M
BLACKROCK, INC.
Shares:11.32M
Value:$64.42M
BLACKROCK INC.
Shares:9.31M
Value:$53M
Summary
Showing Top 3 of 295
About MiMedx Group, Inc.
https://www.mimedx.comMiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $113.72M ▲ | $72.82M ▲ | $16.75M ▲ | 14.73% ▲ | $0.11 ▲ | $28.92M ▲ |
| Q2-2025 | $98.61M ▲ | $67.55M ▲ | $9.62M ▲ | 9.75% ▲ | $0.07 ▲ | $15.51M ▲ |
| Q1-2025 | $88.2M ▼ | $63.4M ▼ | $7.02M ▼ | 7.96% ▼ | $0.05 ▼ | $11.48M ▼ |
| Q4-2024 | $92.91M ▲ | $64.94M ▲ | $7.44M ▼ | 8.01% ▼ | $0.05 ▼ | $14.14M ▲ |
| Q3-2024 | $84.06M | $57.57M | $8.1M | 9.63% | $0.06 | $12.62M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $142.08M ▲ | $318.99M ▲ | $80.04M ▲ | $238.95M ▲ |
| Q2-2025 | $118.87M ▲ | $291.11M ▲ | $74.48M ▲ | $216.62M ▲ |
| Q1-2025 | $106.43M ▲ | $270.42M ▲ | $67.64M ▼ | $202.78M ▲ |
| Q4-2024 | $104.42M ▲ | $263.92M ▲ | $70.81M ▲ | $193.11M ▲ |
| Q3-2024 | $88.8M | $243.89M | $62.88M | $181.01M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $16.75M ▲ | $29.33M ▲ | $-5.26M ▼ | $-857K ▲ | $23.21M ▲ | $25.41M ▲ |
| Q2-2025 | $9.62M ▲ | $14.42M ▲ | $-887K ▼ | $-1.09M ▲ | $12.44M ▲ | $14.42M ▲ |
| Q1-2025 | $7.02M ▼ | $5.3M ▼ | $-406K ▲ | $-2.88M ▼ | $2.02M ▼ | $4.92M ▼ |
| Q4-2024 | $7.44M ▼ | $18.78M ▼ | $-2.77M ▼ | $-400K ▼ | $15.62M ▼ | $18.78M ▲ |
| Q3-2024 | $7.88M | $19.62M | $113K | $27K | $19.76M | $14.4M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Surgical | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ | $40.00M ▲ |
CEO
Joseph H. Capper
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2008-04-02 | Reverse | 647:2000 |
ETFs Holding This Stock
Summary
Showing Top 3 of 127
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
ESSEX WOODLANDS MANAGEMENT, INC.
Shares:28.2M
Value:$160.43M
BLACKROCK, INC.
Shares:11.32M
Value:$64.42M
BLACKROCK INC.
Shares:9.31M
Value:$53M
Summary
Showing Top 3 of 295